CELESTICA INC (CLS) Stock Fundamental Analysis

NYSE:CLS • CA15101Q2071

292.69 USD
+1.36 (+0.47%)
At close: Feb 20, 2026
293 USD
+0.31 (+0.11%)
After Hours: 2/20/2026, 8:24:44 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CLS. CLS was compared to 122 industry peers in the Electronic Equipment, Instruments & Components industry. While CLS has a great profitability rating, there are some minor concerns on its financial health. CLS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CLS was profitable.
  • CLS had a positive operating cash flow in the past year.
  • Each year in the past 5 years CLS has been profitable.
  • CLS had a positive operating cash flow in each of the past 5 years.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.54%, CLS belongs to the top of the industry, outperforming 92.62% of the companies in the same industry.
  • With an excellent Return On Equity value of 37.56%, CLS belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
  • CLS has a better Return On Invested Capital (24.36%) than 99.18% of its industry peers.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of CLS (6.72%) is better than 73.77% of its industry peers.
  • CLS's Profit Margin has improved in the last couple of years.
  • CLS has a better Operating Margin (7.80%) than 72.13% of its industry peers.
  • CLS's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CLS (12.06%) is worse than 75.41% of its industry peers.
  • CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CLS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • CLS has a better Debt to FCF ratio (1.69) than 81.15% of its industry peers.
  • CLS has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • CLS's Debt to Equity ratio of 0.34 is on the low side compared to the rest of the industry. CLS is outperformed by 60.66% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CLS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z N/A
ROIC/WACC2.75
WACC8.87%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • CLS has a Current Ratio of 1.44. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.44, CLS is doing worse than 74.59% of the companies in the same industry.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • CLS has a Quick ratio of 0.88. This is amonst the worse of the industry: CLS underperforms 84.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.59%, which is quite impressive.
  • CLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.67% yearly.
  • Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 28.46%.
  • Measured over the past years, CLS shows a quite strong growth in Revenue. The Revenue has been growing by 16.61% on average per year.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • Based on estimates for the next years, CLS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.06% on average per year.
  • CLS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.15% yearly.
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 48.30, the valuation of CLS can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as CLS.
  • The average S&P500 Price/Earnings ratio is at 26.99. CLS is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 34.85 indicates a quite expensive valuation of CLS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLS is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of CLS to the average of the S&P500 Index (28.06), we can say CLS is valued slightly more expensively.
Industry RankSector Rank
PE 48.3
Fwd PE 34.85
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA is on the same level as the industry average.
  • CLS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 73.39
EV/EBITDA 29.48
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 33.06% in the coming years.
PEG (NY)1.25
PEG (5Y)1.11
EPS Next 2Y37.93%
EPS Next 3Y33.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELESTICA INC

NYSE:CLS (2/20/2026, 8:24:44 PM)

After market: 293 +0.31 (+0.11%)

292.69

+1.36 (+0.47%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners73.66%
Inst Owner Change4.94%
Ins Owners0.59%
Ins Owner Change50.64%
Market Cap33.63B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.11
Price Target270.8 (-7.48%)
Short Float %2.35%
Short Ratio0.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)8.55%
PT rev (3m)40.92%
EPS NQ rev (1m)14.01%
EPS NQ rev (3m)14.81%
EPS NY rev (1m)0%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)10.4%
Revenue NQ rev (3m)12.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.61%
Valuation
Industry RankSector Rank
PE 48.3
Fwd PE 34.85
P/S 2.71
P/FCF 73.39
P/OCF 51
P/B 15.18
P/tB 20.8
EV/EBITDA 29.48
EPS(TTM)6.06
EY2.07%
EPS(NY)8.4
Fwd EY2.87%
FCF(TTM)3.99
FCFY1.36%
OCF(TTM)5.74
OCFY1.96%
SpS107.83
BVpS19.29
TBVpS14.07
PEG (NY)1.25
PEG (5Y)1.11
Graham Number51.28
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z N/A
F-Score7
WACC8.87%
ROIC/WACC2.75
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year55.75%
EBIT Next 3Y35.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 6 / 10 to CLS.


What is the valuation status of CELESTICA INC (CLS) stock?

ChartMill assigns a valuation rating of 3 / 10 to CELESTICA INC (CLS). This can be considered as Overvalued.


What is the profitability of CLS stock?

CELESTICA INC (CLS) has a profitability rating of 7 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS) is 48.3 and the Price/Book (PB) ratio is 15.18.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS) is 4 / 10.